Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia

International Archives of Allergy and Immunology

Volumn 153, Issue 3, 2010, Pages 294-302

  Katoh, Shigeki ^a,b   Nobumoto, Atsuya ^a   Matsumoto, Nobuhiro ^d   Matsumoto, Kiyoshi ^d   Ehara, Naomi ^e   Niki, Toshiro ^c   Inada, Hiroyuki ^c   Nishi, Nozomu ^a   Yamauchi, Akira ^a   Fukushima, Kiyoyasu ^e   Hirashima, Mitsuomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Eikou Hospital   (Japan)

^c Galpharma Co Ltd   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

Apoptosis; Chemotaxis; Eosinophil; Eosinophilic pneumonia; Eotaxin; Galectin 9; Interleukin 5

Indexed keywords

ECALECTIN; EOTAXIN; INTERLEUKIN 5;

ADULT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; LOEFFLER PNEUMONIA; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION;

CHEMOKINE CCL11; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; GALECTINS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY EOSINOPHILIA;

EID: 77952298179     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314371     Document Type: Article

References (31)

1. Liebow AA, Carrington CB: The eosinophil-ic pneumonias. Medicine 1969; 48:251-255.
2. Allen JN, Davis WB: The eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150:1423-1438.
3. Allen JN, Pacht ER, Gadek JE, Davis WB: Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989; 321: 569-574.
4. Allen JN: Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006; 27:142-147.
5. Carrington CB, Addington WW, Goff AM, Madoff IM, Marks A, Schwaber JR, Gaensler EA: Chronic eosinophilic pneumonia. N Engl J Med 1969; 280:787-798.
6. Marchand E, Cordier JF: Idiopathic chronic eosinophilic pneumonia. Semin Respir Crit Care Med 2006; 27:134-141.
7. Katoh S, Taniguchi H, Matsubara Y, Matsu-moto N, Fukushima K, Kadota J, Matsukura S, Kohno S: Overexpression of CD44on alveolar eosinophils with high concentrations of soluble CD44in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia. Allergy 1999; 54:1286-1292.
8. Katoh S, Matsumoto N, Fukushima K, Mu-kae H, Kadota J, Kohno S, Matsukura S: Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. J Allergy Clin Immunol 2000; 106:730-736.
9. Miyazaki E, Nureki S, Fukami T, Shigenaga T, Ando M, Ito K, Ando H, Sugisaki K, Ku-mamoto T, Tsuda T: Elevated levels of thymus-and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med 2002; 165:1125-1131.
10. Katoh S, Fukushima K, Matsumoto N, Matsumoto K, Abe K, Onai N, Matsushima K Matsukura S: Accumulation of CCR4-ex-pressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2003; 58: 518-523.
11. Wada J, Ota K, Kumar A, Wallner EI, Kan-war YS: Developmental regulation, expression and apoptotic potential of galectin-9, a fi-galactoside binding lectin. J Clin Invest 1997; 99: 2452-2461.
12. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hi-rashima M: Human ecalectin, a variant of human galectin-9, is a novel eosinophil che-moattractant produced by T lymphocytes. J Biol Chem 1998; 273: 16976-16984. (Pubitemid 28311730)
13. Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, Abedin MJ, Yoshida N, Ni-shi N, Imaizumi T, Saita N, Toyama Y, Ta-kashima H, Nakamura T, Ohkawa M, Hi-rashima M: Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 2002; 169: 5912-5918.
14. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi T, Kageshita T, Saita N, Nakamura T: Galectin-9 in physiological and pathological conditions. Glycoconj J 2004; 19: 593-600.
15. Yamamoto H, Kashio Y, Shoji H, Shinonaga R , Yoshimu ra T, Nishi N, Nabe T, Naka mu ra T, Kohno S, Hirashima M: Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol 2007; 143(suppl 1):95-105.
16. Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai S, Shinonaga R, Niki T, Nishi N, Tomi-naga A, Yamauchi A, Hirashima M: Galec-tin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med 2007; 176:27-35.
17. Seki M, Sakata K, Oomizu S, Arikawa T, Sakata A, Ueno M, Nobumoto A, Niki T, Saita N, Ito K, Dai S, Katoh S, Nishi N, Tsu-kano M, Ishikawa K, Yamauchi A, Kuchroo VK, Hirashima M: Beneficial effect of galec-tin-9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis R heum 20 07; 56: 39 68-39 76.
18. Nishi N, Itoh A , Fujiyama A , Yoshida N, Ara-ya S, Hirashima M, Shoji H, Nakamura T: Development of highly stable galectins: truncation of the linker peptide confers pro-tease-resistance on tandem-repeat type ga-lectins. FEBS Lett 2005; 579: 2058-2064.
19. Saita N, Goto E, Yamamoto T, Cho I, Tsu-mori K, Kohrogi H, Maruo K, Ono T, Takeya M, Kashio Y, Nakamura K, Hirashima M: Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol 2002; 128:42-50.
20. Tateno H, Nakamura H, Minematsu N, Amakawa K, Terashima T, Fujishima S, Luster AD, Lilly CM, Yamaguchi K: Eotaxin and monocyte chemoattractant protein-1in chronic eosinophilic pneumonia. Eur Respir J 2001; 17:962-968.
21. Nakahara Y, Hayashi S, Fukuno Y, Kawashi-ma M, Yatsunami J: Increased interleukin-5levels in bronchoalveolar fluid is a major factor for eosinophil accumulation in acute eo-sinophilic pneumonia. Respiration 2001; 68: 389-395.
22. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AE, Wells TN, Li D, Jeffery PK, Griffiths-Johnson DA, Williams TJ, Jose PJ: Kinetics of eo-taxin generation and its relationship to eo-sinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 1997; 186: 601-612.
23. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T, Hirashima M: Galectin-9 induces apoptosis through the calcium-calpain-caspase- 1pathway. J Immunol 2003; 170:3631-3636.
24. Seki M, Oomizu S, Sakata S, Sakata A, Ari-kawa T, Watanabe K, Ito K, Takeshita K, Niki T, Saita N, Nishi N, Yamauchi A, Katoh S, Matsukawa A, Kuchroo VK, Hirashima M: Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008; 127:78-88.
25. Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, Tateno H, Watanabe K, Niki T, Katoh S, Miyake M, Nagahata S, Hi-rabayashi J, Kuchroo VK, Yamauchi A, Hi-rashima M: Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3interactions. J Immunol 2008; 181: 7660-7669.
26. Rabinovich AG, Liu FT, Hirashima M: An emerging role for galectins in tuning the immune response: lessons from experimental models of inf la mmator y disease, autoimmu-nity and cancer. Scand J Immunol 2007; 66: 143-158.
27. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwas-kar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA: Promotion of tissue inf lammation by the immune receptor Tim-3expressed on innate immune cells. Science 2007; 318: 1141-1143.
28. Rothenberg ME, Hogan SP: The eosinophil. Annu Rev Immunol 2006; 24:147-174.
29. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME: Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38:709-750.
30. Kay AB, Phipps S, Robinson DS: A role for eosinophils in airway remodeling in asthma. Trends Immunol 2004; 25:477-482. (Pubitemid 39490254)
31. Arikawa T, Matsukawa A, Watanabe K, Sa k ata K, S ek i M, Na gaya ma M, Ta kesh it a K , Ito K, Niki T, Oomizu S, Shinonaga R, Saita N, Hirashima M: Galectin-9 accelerates transforming growth factor beta-3induced differentiation of human mesenchymal stem cells to chondrocy tes. Bone 20 09; 44: 849-857.